A Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson’s Disease Patients
Condition(s):Parkinson’s DiseaseLast Updated:January 18, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Parkinson’s DiseaseLast Updated:January 18, 2024Completed
Condition(s):Parkinson’s Disease With End of Dose Wearing OffLast Updated:March 30, 2017Completed
Condition(s):Parkinson’s DiseaseLast Updated:May 5, 2021Completed
Condition(s):Parkinson’s Disease (PD)Last Updated:August 18, 2020Completed
Condition(s):HealthyLast Updated:August 4, 2023Not yet recruiting
Condition(s):Parkinson’s DiseaseLast Updated:April 30, 2012Withdrawn
Condition(s):HealthyLast Updated:June 22, 2007Completed
Condition(s):HealthyLast Updated:June 22, 2007Completed
Condition(s):HealthyLast Updated:June 22, 2007Completed
Condition(s):HealthyLast Updated:June 22, 2007Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.